TD Waterhouse Canada Inc. - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 35 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
TD Waterhouse Canada Inc. ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$4
-20.0%
80.0%0.00%
Q1 2022$5
-44.4%
80.0%0.00%
Q4 2021$980.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$159,0000.12%
PERKINS CAPITAL MANAGEMENT INC 53,304$106,0000.06%
HATTON CONSULTING, INC. 37,195$74,0000.06%
CRA Financial Services, LLC 19,957$40,0000.01%
StoneX Group Inc. 13,442$27,0000.00%
WEDBUSH SECURITIES INC 32,228$64,0000.00%
QS Investors, LLC 82,000$164,0000.00%
Retirement Group, LLC 2,500$5,0000.00%
Cetera Investment Advisers 45,025$90,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 137,510$273,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders